Key result
A survey of 154 German stroke unit leads revealed that oral anticoagulation is considered feasible in over 90% of acute ischemic stroke patients with atrial fibrillation, though specific prescription modalities vary.
Why the study?
Clinical guideline recommendations are vague regarding oral anticoagulation during the acute phase of ischemic stroke in patients with AF.
Cross-Sectional (n=154)
Yes
Early secondary stroke prevention in AF patients in German stroke units relies heavily on oral anticoagulation, primarily NOACs, though prescription modalities vary.
No takes yet. Share an insight, caveat, or question.
Widespread perceived feasibility of OAC in acute stroke with AF may inform decisions; leaves open standardization of timing and agents.
Wutzler et al. (2019) conducted a cross-sectional in Acute ischemic stroke and atrial fibrillation (n=154). Clinical practice survey on oral anticoagulation was evaluated on Current clinical practice of medical stroke prevention in AF patients during the acute phase of ischemic stroke. A survey of 154 German stroke unit leads revealed that oral anticoagulation is considered feasible in over 90% of acute ischemic stroke patients with atrial fibrillation, though specific prescription modalities vary.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: